News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
ASCO – Rapid guideline update on Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer
Photo taken from ASCO
May 22, 2024, 13:29

ASCO – Rapid guideline update on Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer

ASCO shared a post on LinkedIn:

“Check out our latest rapid guideline update on Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer – CDK4/6 Inhibitors.”

Read further.
Source: ASCO/LinkedIn

adjuvant chemotherapy ASCO Breast Cancer cancer OncoDaily Oncology Targeted Therap
Special Coverage
Societies
Apr 1, 2025, 14:08
Myeloma Paper of the Day, April 1st, suggested by Robert Orlowski
Blog
Apr 1, 2025, 12:54
CTOS Communications Committee: Survey to understand your engagement with social media
Science
Apr 1, 2025, 12:48
Yan Leyfman: Dual-Targeted CAR-T Therapy Shows 100% Response in MCL
Blog
Apr 1, 2025, 12:43
By 2040, the global burden of colorectal cancer is expected to rise by 63% - Digestive Cancers Europe
Blog
Apr 1, 2025, 12:34
Asya Agulnik: Breakthrough approaches needed for pediatric cancer treatment in conflict-affected regions
Blog
Apr 1, 2025, 12:18
What if 'No Response' Becomes 'No Recurrence' in Colorectal Cancer Treatment? - CancerWorld
Blog
Apr 1, 2025, 12:16
Maryam S. Yazdy: From FDA to BeiGene - Embracing a New Chapter
Blog
Apr 1, 2025, 12:13
Mehmet Murat Zerey: Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Blog
Apr 1, 2025, 12:07
Iyad Sultan: Language models struggle with the spatial understanding of human anatomy
Blog
Apr 1, 2025, 12:07
SPCC - How to implement efficiency in Cancer Care Module
Blog
Apr 1, 2025, 11:59
AACR-Ocular Melanoma Foundation grants support ocular/uveal melanoma research
Blog
Apr 1, 2025, 11:54
Are researchers looking for cancer data? - NCI Division of Cancer Control and Population Sciences